Flowchart of the process of study selection LAR indicates laboratory-defined aspirin resistance Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9.

Slides:

Advertisements

Similar presentations

(a) (b) (c) (d). What is (1,2,3)  (3,4,2)? (a) (1, 2, 3, 4) (b) (1,2)  (3,4) (c) (1,3,4,2) (d) (3,1)  (4,2)

Advertisements

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Literature Appraisal Effectiveness of Therapy. Measures of treatment effect Statistical significance Odds ratio Relative risk Absolute risk reduction.

Shalev V, et al. Arch Intern Med 2009; 169:

Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:

Flow diagram of study selection process CAB: Commonwealth Agricultural Bureau Ethan M. Balk, et al. Arch Intern Med. 2007;167:21-30.

Flowchart of study participants MedDiet indicates Mediterranean diet; VOO, virgin olive oil Jordi Salas-Salvado, et al. Arch Intern Med 2008;168:

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.

Date of download: 9/16/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cranberry-Containing Products for Prevention of Urinary.

Copyright © 2016 American Medical Association. All rights reserved.

(p for noninferiority = 0.01)

Copyright © 2005 American Medical Association. All rights reserved.

Copyright © 2012 American Medical Association. All rights reserved.

Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:

Flowchart of participants

Local Breast Cancer Recurrence after Mastectomy and Breast-Conserving Surgery for Paget's Disease: A Meta-Analysis Breast Care 2014;9: DOI: /

Flowchart of participant screening, enrollment, withdrawal, and protocol completion Asterisk indicates those with partial or missing data included in analyses.

Copyright © 2012 American Medical Association. All rights reserved.

SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.

Markov model structure

TNT: Baseline and final LDL cholesterol levels

TNT Study: Baseline Characteristics of the Patients

Should We Use Antibiotic Prophylaxis for Flexible Cystoscopy

PREMIER: Rate of hypertension at 18 months

Time between systemic lupus erythematosus (SLE) and haematological malignancy diagnoses. Time between systemic lupus erythematosus (SLE) and haematological.

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Jun M, et al. Lancet 2010 Epub May 10

Fellström BC, et al. N Engl J Med 2009;360:1455-7

Adjusted odds ratio for hypoglycemia with gatifloxacin and levofloxacin compared with macrolide antibiotics Antibiotic Odds ratio of hypoglycemia 95% CI.

Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.

Factors independently associated with odds of fractures

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

John A. Bittl et al. JACC 2016;68:

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Effect of confidence interval reduction to demonstrate a true difference in means. Effect of confidence interval reduction to demonstrate a true difference.

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Enrollment and Outcomes

Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,

Berger JS, et al. JAMA 2009;301:

Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:

Baseline Characteristics of the Patients and Use of Concomitant Medications – Part I Kaare Harald Bønaa, et al. N Engl J Med 2006;354:

Baseline Characteristics of the Study Participants

Nat. Rev. Cardiol. doi: /nrcardio

Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.

Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:

Flowchart of Manuscript Selection

Relative Risk of Onset of Cancer from the Cholesterol Treatment Trialists’ (CTT) Meta-Analysis of Statin Trials, According to Year of Onset Risk ratios.

Forest plots of randomised controlled trials and propensity score matched studies examining outcomes between patients taking proton pump inhibitor (PPIs)

Kaplan-Meier curves showing the time in months to the first inappropriate shock from the start of remote monitoring in primary and secondary prevention.

Baseline Characteristics of the Patients – Part I

Risk of having any adverse effects with supplements compared with placebo. Risk of having any adverse effects with supplements compared with placebo. Stratified.

Forest plot of adjusted odds ratios (with 95% confidence intervals) from multivariable multinomial logistic regression analysis (table 4), by number of.

Ejection fraction preoperatively and at follow-up in conventional (C) and no-touch (NT) groups. Ejection fraction preoperatively and at follow-up in conventional.

Forest plot of studies examining outcomes between patients taking proton pump inhibitor (PPIs) with clopidogrel and those taking only clopidogrel: (A)

Forest plot and pooled estimates of the effect of NAFLD on the risk of incident diabetes in 16 eligible studies, stratified by length of follow-up (FU)

Forest plot illustrating the risk ratio of any bleeding and GRADE assessment. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI,

Forest plot of the association between early coronary angiography and survival in patients with out-of-hospital cardiac arrest A: including unadjusted.

Outcomes Group Number of events Total person-years aIRR (95%CI)

Outcomes Number of events† Total person-years† aHR‡ (95%CI)

Outcomes Number of events† Total person-years† aHR‡ (95%CI)

Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Forest plot illustrating the risk ratio of major bleeding

Percentage of total mortality cases from CHD, CVD, and other causes (A). Percentage of total mortality cases from CHD, CVD, and other causes (A). Mortality.

Forest plots of pooled studies ultrasound-guided lavage with a corticosteroid injection to shockwave therapy for change in pain in patient with chronic.

Forest plot of major bleeding: the measure of the effect of morphine versus nonmorphine on major bleeding in each study was plotted using OR and 95% CI.

Forest plot illustrating the risk ratio of myocardial infarction

Forest plot illustrating risk ratio of stent thrombosis

Forest plot of platelet-rich plasma (PRP) versus control on tendinopathy pain. Forest plot of platelet-rich plasma (PRP) versus control on tendinopathy.

Forest plot for one-study removed sensitivity analysis of platelet-rich plasma (PRP) versus control on tendinopathy pain. Forest plot for one-study removed.

Forest plot showing ORs for manual/unskilled occupation in adulthood for those with a mental health condition in adolescence in individual studies and.

Presentation transcript:

Flowchart of the process of study selection LAR indicates laboratory-defined aspirin resistance Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

Details of Included Studies – Part I Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

Details of Included Studies – Part II Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

Details of Included Studies – References Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

Statistical Details of Included Studies Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9

Forest plots of odds ratios (ORs) of the cardiovascular outcome for patients with LAR vs those without LAR from eligible studies Jaapjan D. Snoep, et al. Arch Intern Med 2007;167:1593-9